Compare AUTL & RFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUTL | RFI |
|---|---|---|
| Founded | 2014 | 1992 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 368.6M | 301.7M |
| IPO Year | 2018 | N/A |
| Metric | AUTL | RFI |
|---|---|---|
| Price | $1.55 | $11.20 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.33 | N/A |
| AVG Volume (30 Days) | ★ 3.9M | 69.8K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.25% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $51,128,000.00 | N/A |
| Revenue This Year | $658.11 | N/A |
| Revenue Next Year | $91.34 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 406.67 | N/A |
| 52 Week Low | $1.11 | $9.62 |
| 52 Week High | $3.11 | $12.52 |
| Indicator | AUTL | RFI |
|---|---|---|
| Relative Strength Index (RSI) | 58.56 | 38.47 |
| Support Level | $1.31 | $11.06 |
| Resistance Level | $1.61 | $11.46 |
| Average True Range (ATR) | 0.09 | 0.13 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 85.37 | 31.65 |
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
Cohen & Steers Total Return Realty Fund Inc is a diversified, closed-end management investment company. Its investment objective is to achieve a high total return through investment in real estate securities. The Fund invests majority of its total assets in the equity securities of real estate companies under normal circumstances, which includes common shares, REITs, rights or warrants, convertible securities, and preferred shares.